nodes	percent_of_prediction	percent_of_DWPC	metapath
Diatrizoate—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Diatrizoate—Cough—Irinotecan—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Diatrizoate—Leukopenia—Gemcitabine—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Diatrizoate—Renal failure—Docetaxel—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Diatrizoate—Myocardial infarction—Docetaxel—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Diatrizoate—Hypertension—Irinotecan—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Diatrizoate—Conjunctivitis—Docetaxel—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Diatrizoate—Leukopenia—Fluorouracil—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Diatrizoate—Cough—Gemcitabine—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Diatrizoate—Pain—Sunitinib—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Diatrizoate—Hypertension—Gemcitabine—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Diatrizoate—Renal failure acute—Epirubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Diatrizoate—Asthenia—Tamoxifen—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Convulsion—Fluorouracil—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Chest pain—Gemcitabine—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Confusional state—Irinotecan—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Diatrizoate—Asthenia—Erlotinib—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Diatrizoate—Pruritus—Tamoxifen—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Oedema—Irinotecan—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Chest pain—Fluorouracil—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Infection—Irinotecan—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Diatrizoate—Pruritus—Erlotinib—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Diatrizoate—Shock—Irinotecan—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Diatrizoate—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Diatrizoate—Haemoglobin—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Diatrizoate—Rhinitis—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Diatrizoate—Oedema—Gemcitabine—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Diatrizoate—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Diatrizoate—Haemorrhage—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Diatrizoate—Diarrhoea—Tamoxifen—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Infection—Gemcitabine—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Confusional state—Fluorouracil—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Body temperature increased—Sunitinib—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Diatrizoate—Diarrhoea—Erlotinib—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Diatrizoate—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Diatrizoate—Oedema—Fluorouracil—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Diatrizoate—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Diatrizoate—Infection—Fluorouracil—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Diatrizoate—Renal failure acute—Doxorubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Diatrizoate—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Diatrizoate—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Diatrizoate—Dizziness—Tamoxifen—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Diatrizoate—Tachycardia—Fluorouracil—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Diatrizoate—Hypotension—Irinotecan—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Diatrizoate—Dizziness—Erlotinib—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Diatrizoate—Face oedema—Epirubicin—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Diatrizoate—Hypotension—Gemcitabine—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Diatrizoate—Flushing—Docetaxel—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Diatrizoate—Cardiac arrest—Epirubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Diatrizoate—Vomiting—Tamoxifen—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Diatrizoate—Paraesthesia—Irinotecan—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Diatrizoate—Hypotension—Fluorouracil—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Diatrizoate—Rash—Tamoxifen—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Diatrizoate—Dermatitis—Tamoxifen—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Diatrizoate—Vomiting—Erlotinib—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Diatrizoate—Dyspnoea—Irinotecan—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Diatrizoate—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Diatrizoate—Headache—Tamoxifen—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Diatrizoate—Rash—Erlotinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Diatrizoate—Dermatitis—Erlotinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Diatrizoate—Headache—Erlotinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Diatrizoate—Paraesthesia—Gemcitabine—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Diatrizoate—Chills—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Diatrizoate—Asthenia—Sunitinib—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Diatrizoate—Arrhythmia—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Diatrizoate—Dyspnoea—Gemcitabine—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Diatrizoate—Paraesthesia—Fluorouracil—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Diatrizoate—Pruritus—Sunitinib—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Diatrizoate—Pain—Irinotecan—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Diatrizoate—Dyspnoea—Fluorouracil—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Diatrizoate—Face oedema—Doxorubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Diatrizoate—Erythema—Docetaxel—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Diatrizoate—Nausea—Tamoxifen—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Diatrizoate—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Diatrizoate—Pain—Gemcitabine—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Diatrizoate—Nausea—Erlotinib—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Diatrizoate—Diarrhoea—Sunitinib—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Diatrizoate—Dysgeusia—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Diatrizoate—Feeling abnormal—Irinotecan—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Diatrizoate—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Diatrizoate—Asthma—Epirubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Diatrizoate—Pain—Fluorouracil—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Diatrizoate—Muscle spasms—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Diatrizoate—Dizziness—Sunitinib—pancreatic cancer	0.001	0.001	CcSEcCtD
Diatrizoate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.001	0.001	CcSEcCtD
Diatrizoate—Body temperature increased—Irinotecan—pancreatic cancer	0.000987	0.000987	CcSEcCtD
Diatrizoate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000986	0.000986	CcSEcCtD
Diatrizoate—Anaemia—Docetaxel—pancreatic cancer	0.000978	0.000978	CcSEcCtD
Diatrizoate—Vomiting—Sunitinib—pancreatic cancer	0.000964	0.000964	CcSEcCtD
Diatrizoate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000962	0.000962	CcSEcCtD
Diatrizoate—Neutropenia—Epirubicin—pancreatic cancer	0.000958	0.000958	CcSEcCtD
Diatrizoate—Rash—Sunitinib—pancreatic cancer	0.000956	0.000956	CcSEcCtD
Diatrizoate—Dermatitis—Sunitinib—pancreatic cancer	0.000955	0.000955	CcSEcCtD
Diatrizoate—Urticaria—Fluorouracil—pancreatic cancer	0.00095	0.00095	CcSEcCtD
Diatrizoate—Headache—Sunitinib—pancreatic cancer	0.00095	0.00095	CcSEcCtD
Diatrizoate—Asthma—Doxorubicin—pancreatic cancer	0.000948	0.000948	CcSEcCtD
Diatrizoate—Leukopenia—Docetaxel—pancreatic cancer	0.000947	0.000947	CcSEcCtD
Diatrizoate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000946	0.000946	CcSEcCtD
Diatrizoate—Loss of consciousness—Docetaxel—pancreatic cancer	0.00093	0.00093	CcSEcCtD
Diatrizoate—Cough—Docetaxel—pancreatic cancer	0.000923	0.000923	CcSEcCtD
Diatrizoate—Convulsion—Docetaxel—pancreatic cancer	0.000917	0.000917	CcSEcCtD
Diatrizoate—Hypertension—Docetaxel—pancreatic cancer	0.000913	0.000913	CcSEcCtD
Diatrizoate—Chest pain—Docetaxel—pancreatic cancer	0.000901	0.000901	CcSEcCtD
Diatrizoate—Nausea—Sunitinib—pancreatic cancer	0.000901	0.000901	CcSEcCtD
Diatrizoate—Renal failure—Epirubicin—pancreatic cancer	0.000898	0.000898	CcSEcCtD
Diatrizoate—Asthenia—Irinotecan—pancreatic cancer	0.000896	0.000896	CcSEcCtD
Diatrizoate—Conjunctivitis—Epirubicin—pancreatic cancer	0.000888	0.000888	CcSEcCtD
Diatrizoate—Neutropenia—Doxorubicin—pancreatic cancer	0.000886	0.000886	CcSEcCtD
Diatrizoate—Sweating—Epirubicin—pancreatic cancer	0.000875	0.000875	CcSEcCtD
Diatrizoate—Asthenia—Gemcitabine—pancreatic cancer	0.000873	0.000873	CcSEcCtD
Diatrizoate—Haematuria—Epirubicin—pancreatic cancer	0.000871	0.000871	CcSEcCtD
Diatrizoate—Confusional state—Docetaxel—pancreatic cancer	0.000871	0.000871	CcSEcCtD
Diatrizoate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000863	0.000863	CcSEcCtD
Diatrizoate—Oedema—Docetaxel—pancreatic cancer	0.000863	0.000863	CcSEcCtD
Diatrizoate—Pruritus—Gemcitabine—pancreatic cancer	0.000861	0.000861	CcSEcCtD
Diatrizoate—Infection—Docetaxel—pancreatic cancer	0.000858	0.000858	CcSEcCtD
Diatrizoate—Diarrhoea—Irinotecan—pancreatic cancer	0.000855	0.000855	CcSEcCtD
Diatrizoate—Shock—Docetaxel—pancreatic cancer	0.000849	0.000849	CcSEcCtD
Diatrizoate—Pruritus—Fluorouracil—pancreatic cancer	0.000846	0.000846	CcSEcCtD
Diatrizoate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000845	0.000845	CcSEcCtD
Diatrizoate—Tachycardia—Docetaxel—pancreatic cancer	0.000843	0.000843	CcSEcCtD
Diatrizoate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000832	0.000832	CcSEcCtD
Diatrizoate—Renal failure—Doxorubicin—pancreatic cancer	0.000831	0.000831	CcSEcCtD
Diatrizoate—Dizziness—Irinotecan—pancreatic cancer	0.000826	0.000826	CcSEcCtD
Diatrizoate—Haemoglobin—Epirubicin—pancreatic cancer	0.000824	0.000824	CcSEcCtD
Diatrizoate—Rhinitis—Epirubicin—pancreatic cancer	0.000822	0.000822	CcSEcCtD
Diatrizoate—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000821	0.000821	CcSEcCtD
Diatrizoate—Haemorrhage—Epirubicin—pancreatic cancer	0.00082	0.00082	CcSEcCtD
Diatrizoate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000819	0.000819	CcSEcCtD
Diatrizoate—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000816	0.000816	CcSEcCtD
Diatrizoate—Sweating—Doxorubicin—pancreatic cancer	0.00081	0.00081	CcSEcCtD
Diatrizoate—Hypotension—Docetaxel—pancreatic cancer	0.000807	0.000807	CcSEcCtD
Diatrizoate—Haematuria—Doxorubicin—pancreatic cancer	0.000806	0.000806	CcSEcCtD
Diatrizoate—Vomiting—Irinotecan—pancreatic cancer	0.000794	0.000794	CcSEcCtD
Diatrizoate—Dizziness—Fluorouracil—pancreatic cancer	0.000791	0.000791	CcSEcCtD
Diatrizoate—Rash—Irinotecan—pancreatic cancer	0.000788	0.000788	CcSEcCtD
Diatrizoate—Dermatitis—Irinotecan—pancreatic cancer	0.000787	0.000787	CcSEcCtD
Diatrizoate—Headache—Irinotecan—pancreatic cancer	0.000782	0.000782	CcSEcCtD
Diatrizoate—Paraesthesia—Docetaxel—pancreatic cancer	0.000775	0.000775	CcSEcCtD
Diatrizoate—Vomiting—Gemcitabine—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Diatrizoate—Dyspnoea—Docetaxel—pancreatic cancer	0.00077	0.00077	CcSEcCtD
Diatrizoate—Rash—Gemcitabine—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Diatrizoate—Dermatitis—Gemcitabine—pancreatic cancer	0.000766	0.000766	CcSEcCtD
Diatrizoate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000762	0.000762	CcSEcCtD
Diatrizoate—Headache—Gemcitabine—pancreatic cancer	0.000762	0.000762	CcSEcCtD
Diatrizoate—Flushing—Epirubicin—pancreatic cancer	0.000761	0.000761	CcSEcCtD
Diatrizoate—Vomiting—Fluorouracil—pancreatic cancer	0.000761	0.000761	CcSEcCtD
Diatrizoate—Rhinitis—Doxorubicin—pancreatic cancer	0.00076	0.00076	CcSEcCtD
Diatrizoate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000758	0.000758	CcSEcCtD
Diatrizoate—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000755	0.000755	CcSEcCtD
Diatrizoate—Rash—Fluorouracil—pancreatic cancer	0.000754	0.000754	CcSEcCtD
Diatrizoate—Dermatitis—Fluorouracil—pancreatic cancer	0.000754	0.000754	CcSEcCtD
Diatrizoate—Headache—Fluorouracil—pancreatic cancer	0.000749	0.000749	CcSEcCtD
Diatrizoate—Nausea—Irinotecan—pancreatic cancer	0.000742	0.000742	CcSEcCtD
Diatrizoate—Pain—Docetaxel—pancreatic cancer	0.000738	0.000738	CcSEcCtD
Diatrizoate—Chills—Epirubicin—pancreatic cancer	0.000736	0.000736	CcSEcCtD
Diatrizoate—Arrhythmia—Epirubicin—pancreatic cancer	0.000732	0.000732	CcSEcCtD
Diatrizoate—Nausea—Gemcitabine—pancreatic cancer	0.000723	0.000723	CcSEcCtD
Diatrizoate—Erythema—Epirubicin—pancreatic cancer	0.000714	0.000714	CcSEcCtD
Diatrizoate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Diatrizoate—Nausea—Fluorouracil—pancreatic cancer	0.000711	0.000711	CcSEcCtD
Diatrizoate—Flushing—Doxorubicin—pancreatic cancer	0.000704	0.000704	CcSEcCtD
Diatrizoate—Dysgeusia—Epirubicin—pancreatic cancer	0.000699	0.000699	CcSEcCtD
Diatrizoate—Muscle spasms—Epirubicin—pancreatic cancer	0.000686	0.000686	CcSEcCtD
Diatrizoate—Body temperature increased—Docetaxel—pancreatic cancer	0.000683	0.000683	CcSEcCtD
Diatrizoate—Chills—Doxorubicin—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Diatrizoate—Arrhythmia—Doxorubicin—pancreatic cancer	0.000678	0.000678	CcSEcCtD
Diatrizoate—Erythema—Doxorubicin—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Diatrizoate—Anaemia—Epirubicin—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Diatrizoate—Agitation—Epirubicin—pancreatic cancer	0.000656	0.000656	CcSEcCtD
Diatrizoate—Dysgeusia—Doxorubicin—pancreatic cancer	0.000647	0.000647	CcSEcCtD
Diatrizoate—Leukopenia—Epirubicin—pancreatic cancer	0.000639	0.000639	CcSEcCtD
Diatrizoate—Muscle spasms—Doxorubicin—pancreatic cancer	0.000635	0.000635	CcSEcCtD
Diatrizoate—Loss of consciousness—Epirubicin—pancreatic cancer	0.000627	0.000627	CcSEcCtD
Diatrizoate—Cough—Epirubicin—pancreatic cancer	0.000623	0.000623	CcSEcCtD
Diatrizoate—Asthenia—Docetaxel—pancreatic cancer	0.000619	0.000619	CcSEcCtD
Diatrizoate—Convulsion—Epirubicin—pancreatic cancer	0.000618	0.000618	CcSEcCtD
Diatrizoate—Hypertension—Epirubicin—pancreatic cancer	0.000616	0.000616	CcSEcCtD
Diatrizoate—Pruritus—Docetaxel—pancreatic cancer	0.000611	0.000611	CcSEcCtD
Diatrizoate—Anaemia—Doxorubicin—pancreatic cancer	0.00061	0.00061	CcSEcCtD
Diatrizoate—Chest pain—Epirubicin—pancreatic cancer	0.000608	0.000608	CcSEcCtD
Diatrizoate—Agitation—Doxorubicin—pancreatic cancer	0.000607	0.000607	CcSEcCtD
Diatrizoate—Leukopenia—Doxorubicin—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Diatrizoate—Diarrhoea—Docetaxel—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Diatrizoate—Confusional state—Epirubicin—pancreatic cancer	0.000587	0.000587	CcSEcCtD
Diatrizoate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000582	0.000582	CcSEcCtD
Diatrizoate—Oedema—Epirubicin—pancreatic cancer	0.000582	0.000582	CcSEcCtD
Diatrizoate—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Diatrizoate—Infection—Epirubicin—pancreatic cancer	0.000579	0.000579	CcSEcCtD
Diatrizoate—Cough—Doxorubicin—pancreatic cancer	0.000576	0.000576	CcSEcCtD
Diatrizoate—Shock—Epirubicin—pancreatic cancer	0.000573	0.000573	CcSEcCtD
Diatrizoate—Convulsion—Doxorubicin—pancreatic cancer	0.000572	0.000572	CcSEcCtD
Diatrizoate—Dizziness—Docetaxel—pancreatic cancer	0.000571	0.000571	CcSEcCtD
Diatrizoate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Diatrizoate—Hypertension—Doxorubicin—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Diatrizoate—Tachycardia—Epirubicin—pancreatic cancer	0.000568	0.000568	CcSEcCtD
Diatrizoate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000563	0.000563	CcSEcCtD
Diatrizoate—Chest pain—Doxorubicin—pancreatic cancer	0.000562	0.000562	CcSEcCtD
Diatrizoate—Vomiting—Docetaxel—pancreatic cancer	0.000549	0.000549	CcSEcCtD
Diatrizoate—Rash—Docetaxel—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Diatrizoate—Hypotension—Epirubicin—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Diatrizoate—Dermatitis—Docetaxel—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Diatrizoate—Confusional state—Doxorubicin—pancreatic cancer	0.000543	0.000543	CcSEcCtD
Diatrizoate—Headache—Docetaxel—pancreatic cancer	0.000541	0.000541	CcSEcCtD
Diatrizoate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Diatrizoate—Oedema—Doxorubicin—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Diatrizoate—Infection—Doxorubicin—pancreatic cancer	0.000535	0.000535	CcSEcCtD
Diatrizoate—Shock—Doxorubicin—pancreatic cancer	0.00053	0.00053	CcSEcCtD
Diatrizoate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000528	0.000528	CcSEcCtD
Diatrizoate—Tachycardia—Doxorubicin—pancreatic cancer	0.000526	0.000526	CcSEcCtD
Diatrizoate—Paraesthesia—Epirubicin—pancreatic cancer	0.000523	0.000523	CcSEcCtD
Diatrizoate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000521	0.000521	CcSEcCtD
Diatrizoate—Dyspnoea—Epirubicin—pancreatic cancer	0.000519	0.000519	CcSEcCtD
Diatrizoate—Nausea—Docetaxel—pancreatic cancer	0.000513	0.000513	CcSEcCtD
Diatrizoate—Hypotension—Doxorubicin—pancreatic cancer	0.000504	0.000504	CcSEcCtD
Diatrizoate—Pain—Epirubicin—pancreatic cancer	0.000498	0.000498	CcSEcCtD
Diatrizoate—Paraesthesia—Doxorubicin—pancreatic cancer	0.000484	0.000484	CcSEcCtD
Diatrizoate—Dyspnoea—Doxorubicin—pancreatic cancer	0.00048	0.00048	CcSEcCtD
Diatrizoate—Feeling abnormal—Epirubicin—pancreatic cancer	0.00048	0.00048	CcSEcCtD
Diatrizoate—Urticaria—Epirubicin—pancreatic cancer	0.000463	0.000463	CcSEcCtD
Diatrizoate—Pain—Doxorubicin—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Diatrizoate—Body temperature increased—Epirubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Diatrizoate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000444	0.000444	CcSEcCtD
Diatrizoate—Urticaria—Doxorubicin—pancreatic cancer	0.000428	0.000428	CcSEcCtD
Diatrizoate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Diatrizoate—Asthenia—Epirubicin—pancreatic cancer	0.000418	0.000418	CcSEcCtD
Diatrizoate—Pruritus—Epirubicin—pancreatic cancer	0.000412	0.000412	CcSEcCtD
Diatrizoate—Diarrhoea—Epirubicin—pancreatic cancer	0.000398	0.000398	CcSEcCtD
Diatrizoate—Asthenia—Doxorubicin—pancreatic cancer	0.000387	0.000387	CcSEcCtD
Diatrizoate—Dizziness—Epirubicin—pancreatic cancer	0.000385	0.000385	CcSEcCtD
Diatrizoate—Pruritus—Doxorubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Diatrizoate—Vomiting—Epirubicin—pancreatic cancer	0.00037	0.00037	CcSEcCtD
Diatrizoate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000369	0.000369	CcSEcCtD
Diatrizoate—Rash—Epirubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Diatrizoate—Dermatitis—Epirubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Diatrizoate—Headache—Epirubicin—pancreatic cancer	0.000365	0.000365	CcSEcCtD
Diatrizoate—Dizziness—Doxorubicin—pancreatic cancer	0.000356	0.000356	CcSEcCtD
Diatrizoate—Nausea—Epirubicin—pancreatic cancer	0.000346	0.000346	CcSEcCtD
Diatrizoate—Vomiting—Doxorubicin—pancreatic cancer	0.000343	0.000343	CcSEcCtD
Diatrizoate—Rash—Doxorubicin—pancreatic cancer	0.00034	0.00034	CcSEcCtD
Diatrizoate—Dermatitis—Doxorubicin—pancreatic cancer	0.000339	0.000339	CcSEcCtD
Diatrizoate—Headache—Doxorubicin—pancreatic cancer	0.000338	0.000338	CcSEcCtD
Diatrizoate—Nausea—Doxorubicin—pancreatic cancer	0.00032	0.00032	CcSEcCtD
